CA139-ED-X

MRI of Hypertrophic Cardiomyopathy: Phenotypes and Phenocopies

All Day Room: CA Community, Learning Center



Awards
Cum Laude

Cristina Mendez, MD, La Coruna, Spain (Abstract Co-Author) Nothing to Disclose
Susana A. Otero Muinelo, MD, A Coruna, Spain (Presenter) Nothing to Disclose
Tania Perez Ramos, MD, A Coruna, Spain (Abstract Co-Author) Nothing to Disclose
Rafaela Soler, MD, La Coruna, Spain (Abstract Co-Author) Nothing to Disclose
Esther Rodriguez, MA, A Coruna, Spain (Abstract Co-Author) Nothing to Disclose
Roberto Barriales Villa, A Coruna, Spain (Abstract Co-Author) Nothing to Disclose
Juan Pablo Ochoa, A Coruna, Spain (Abstract Co-Author) Nothing to Disclose
Lorenzo Monserrat Iglesias, A Coruna, Spain (Abstract Co-Author) Nothing to Disclose
TEACHING POINTS

To know the different phenotypes of hypertrophic cardiomyopathy (HCM) and their significance. To recognize those MRI findings that establish the differential diagnosis between HCM and its phenocopies.

TABLE OF CONTENTS/OUTLINE

Introduction. Cardiac MRI for morpho-functional characterization of the LV in patients with positive genotype/negative phenotype for HCM, classic phenotypical presentation, adverse remodeling of the LV and end-stage disease. HCM phenocopies: physiologic LV remodeling in athlete’s heart, increased LV afterload due to systemic arterial hypertension or aortic stenosis, LV non-compaction, infiltrative diseases (cardiac amyloidosis and other storage diseases) and endomyocardial disease. Conclusion.